None listed
Conditions
Interventions
Intake of peptide for 4 weeks
Intake of placebo for 4 weeks
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects who are age of 20 years or older. 2. Subjects who received an enough explanation of the test objectives and detail, who have consent ability, who are willing to participate with well understandings and who have signed the informed consent document.
Exclusion criteria
Exclusion criteria: 1. Subjects who have a history of serious illness. 2. Subjects who are under treatment with medication for lifestyle-related disease (diabetes, hypertension, dyslipidemia). 3. Subjects who have digestive tract diseases that affect digestion and absorption, and have had a history of gastrointestinal surgery (excluding appendicitis). 4. Subjects who have a medical history of serious allergy to medicine and food. 5. Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study. 6. Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. 7. Subjects who are planning to participate in other clinical studies. 8. Subjects who are judged unsuitable for participating in this study by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematologic test Biochemistry test Urinalysis Blood pressure/pulse Weight/body mass index Medical interview Adverse event and side effect | — |
Countries
Japan
Contacts
Public ContactEiji Yoshikawa
KSO Corporation Sales department
Outcome results
None listed